Loading NVO…
Loading profile data…Frequently asked questions about NVO
What does Novo Nordisk A/S (NVO) do?
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segmen
Where does NVO trade?
Novo Nordisk A/S (NVO) trades on the New York Stock Exchange.
What sector is NVO in?
Novo Nordisk A/S (NVO) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Novo Nordisk A/S?
Maziar Mike Doustdar is the chief executive officer of Novo Nordisk A/S (NVO).
Where is Novo Nordisk A/S headquartered?
Novo Nordisk A/S is headquartered in Denmark.
When did NVO go public?
Novo Nordisk A/S (NVO) completed its initial public offering in 1981.
Is NVO an ADR?
Yes — NVO is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Novo Nordisk A/S reporting and dividends follow the underlying issuer.